Stay updated on Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the terminated pembrolizumab and mifepristone breast cancer study, including its eligibility criteria, treatment plan, and outcome measures.
    Difference
    50%
    Check dated 2026-11-10T19:56:16.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T20:13:19.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision number changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:35:41.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T19:44:07.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with an access-denied screen.
    Difference
    19%
    Check dated 2026-09-22T21:44:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.7.0, replacing the previous v3.6.6, indicating a behind-the-scenes software update.
    Difference
    0.1%
    Check dated 2026-09-15T21:34:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.